Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
2.750
-0.020 (-0.72%)
At close: Jul 7, 2025, 4:00 PM
2.790
+0.040 (1.45%)
Pre-market: Jul 8, 2025, 7:56 AM EDT
Atai Life Sciences Market Cap
Atai Life Sciences has a market cap or net worth of $583.40 million as of July 8, 2025. Its market cap has increased by 174.40% in one year.
Market Cap
583.40M
Enterprise Value
514.16M
1-Year Change
174.40%
Ranking
Category
Stock Price
$2.75
Market Cap Chart
Since the IPO on June 18, 2021, Atai Life Sciences's market cap has decreased from $2.29B to $583.40M, a decrease of -74.51%. That is a compound annual growth rate of -28.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2025 | 583.40M | 161.40% |
| Dec 31, 2024 | 223.18M | -4.66% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |